Reed Jobs称Yosemite用AI加速癌症治疗,避开姓氏话题

Reed Jobs would rather talk about curing cancer than his last name

精选理由

Reed Jobs的Yosemite用AI搞癌症治疗,还抓住专利过期窗口,这次访谈很实在。

AI 摘要

Reed Jobs的Yosemite风投公司目前有17人团队。他称AI已成为公司核心业务,远超预期。约在同一时期,多个重磅药物专利到期,为生物技术创造新机会。Yosemite专注于利用AI和资本推动癌症治疗创新。

图片来源 · techcrunch
原文 · techcrunch

Reed Jobs would rather talk about curing cancer than his last name

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.